{
  "main_header": {
    "sid": 317368,
    "name": "Torrent Pharma",
    "stock_name": "Torrent Pharma",
    "full_name": "Torrent Pharmaceuticals Ltd.",
    "name_url": "stocks-analysis/torrent-pharma",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "3,777.00",
    "chg": -24.65,
    "chgp": "-0.65%",
    "dir": -1,
    "prev_price": "3,801.65",
    "mcapval": "127,825.10 Cr",
    "mcap": "Large Cap",
    "scripcode": 500420,
    "symbol": "TORNTPHARM",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE685A01028",
    "curr_date": "Dec 05",
    "curr_time": "",
    "bse_nse_vol": "22.3 k",
    "exc_status": "Active",
    "traded_date": "Dec 05, 2025",
    "traded_date_str": "2025 12 05",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/torrent-pharma-317368-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Torrent Pharmaceuticals: Analytical Perspective Shifts Amid Mixed Technical and Financial Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/marketsmojo-downgrades-torrent-pharmaceuticals-to-hold-amid-mixed-technical-and-valuation-signals-3740610",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/TorrentPharmace_mojoScore_3740610.png",
        "date": "2025-12-02 08:32:49",
        "description": "Torrent Pharmaceuticals has experienced a revision in its market assessment following a detailed review of its technical indicators, valuation metrics, financial trends, and overall quality parameters. This nuanced shift reflects a complex interplay of factors influencing the pharmaceutical giant’s current standing in the market."
      },
      {
        "title": "Is Torrent Pharma technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-torrent-pharma-technically-bullish-or-bearish-3740002",
        "imagepath": "",
        "date": "2025-12-02 08:25:25",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Technical Trend Overview</strong></p>\n<p>As of 1 December 2025, Torrent Pharma’s technical trend has moderated from bullish to mildly bullish. This subtle shift suggests that while the stock retains an overall positive momentum, some caution is warranted given mixed signals from various technical tools. Investors should consider this tempered optimism in the context of broader market conditions and sector dynamics.</p>\n<p><strong>Key Technical Indicators</strong></p>\n<p>The Moving Average Convergence Divergence (MACD) indicator offers a split view: weekly data remains bullish, signalling short-term momentum in favour of buyers, whereas the monthly MACD is mildly bearish, hinting at some longer-term caution. This divergence suggests that while recent price action is positive, underlying momen..."
      },
      {
        "title": "Technical Momentum Shift Observed in Torrent Pharmaceuticals Amid Mixed Indicator Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/technical-momentum-shifts-temper-torrent-pharmaceuticals-outlook-despite-strong-returns-3739946",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/TorrentPharmace_technicaldot_3739946.png",
        "date": "2025-12-02 08:03:49",
        "description": "Torrent Pharmaceuticals has experienced a nuanced shift in its technical momentum, reflecting a complex interplay of bullish and mildly bearish signals across key indicators. This development invites a closer examination of the stock’s price action and technical parameters amid the broader Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "How has been the historical performance of Torrent Pharma?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-torrent-pharma-3739257",
        "imagepath": "",
        "date": "2025-12-01 23:14:30",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Revenue and Profit Growth</strong></p>\n<p>Over the seven-year period ending March 2025, Torrent Pharma’s net sales have shown a steady upward trend, increasing from ₹7,673 crores in 2019 to ₹11,516 crores in 2025. This represents a compound growth trajectory reflecting the company’s expanding market presence and product portfolio. The operating profit margin has also improved, rising from 26.6% in 2019 to 32.9% in 2025, signalling enhanced operational efficiency and cost management.</p>\n<p>Profit after tax (PAT) has seen a significant rise, from ₹436 crores in 2019 to ₹1,911 crores in 2025. This growth is supported by a consistent increase in earnings per share (EPS), which climbed from ₹25.76 in 2019 to ₹56.46 in 2025, indicating strong shareholder value creation. The PAT margin improved fr..."
      },
      {
        "title": "Torrent Pharmaceuticals Sees Shift in Market Assessment Amid Strong Financial and Technical Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/marketsmojo-upgrades-torrent-pharmaceuticals-to-buy-on-strong-fundamentals-and-technicals-3732619",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/TorrentPharmace_mojoScore_3732619.png",
        "date": "2025-11-27 08:09:12",
        "description": "Torrent Pharmaceuticals has experienced a notable revision in its market evaluation, reflecting a combination of robust financial performance, evolving technical indicators, and valuation considerations. This article analyses the key factors influencing the recent shift in the company’s assessment across quality, valuation, financial trends, and technical parameters."
      },
      {
        "title": "Technical Momentum Shifts Signal New Phase for Torrent Pharmaceuticals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/torrent-pharmaceuticals-technical-momentum-shifts-signal-bullish-outlook-3732373",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/TorrentPharmace_technicaldot_3732373.png",
        "date": "2025-11-27 08:01:58",
        "description": "Torrent Pharmaceuticals has exhibited a notable shift in its technical momentum, reflecting evolving market dynamics within the Pharmaceuticals & Biotechnology sector. Recent assessment changes highlight a transition towards a more bullish technical stance, supported by key indicators such as MACD, moving averages, and Bollinger Bands, while some oscillators present a more nuanced picture."
      },
      {
        "title": "Surge in Open Interest Signals Shifting Market Dynamics for Torrent Pharmaceuticals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/surge-in-open-interest-signals-shifting-market-sentiment-for-torrent-pharmaceuticals-3725764",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/TorrentPharmace_oi_spurts_by_underlying_3725764.png",
        "date": "2025-11-24 15:00:19",
        "description": "Torrent Pharmaceuticals has witnessed a notable surge in open interest within its derivatives segment, reflecting evolving market positioning and potential directional bets. This development comes amid a backdrop of mixed volume patterns and price movements, offering investors a nuanced view of the stock’s near-term outlook."
      },
      {
        "title": "Surge in Open Interest Signals Shifting Market Dynamics for Torrent Pharmaceuticals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/surge-in-open-interest-signals-shifting-market-sentiment-for-torrent-pharmaceuticals-3725626",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/TorrentPharmace_oi_spurts_by_underlying_3725626.png",
        "date": "2025-11-24 14:00:20",
        "description": "Torrent Pharmaceuticals has witnessed a notable surge in open interest within its derivatives segment, reflecting evolving market positioning and potential directional bets. This development comes amid a backdrop of mixed price action and changing volume patterns, offering investors a nuanced view of the stock’s near-term outlook."
      },
      {
        "title": "Torrent Pharmaceuticals Sees Notable Surge in Open Interest Amidst Market Activity",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/torrent-pharmaceuticals-sees-sharp-open-interest-surge-amid-mixed-market-signals-3718356",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/TorrentPharmace_oi_spurts_by_underlying_3718356.png",
        "date": "2025-11-20 15:00:20",
        "description": "Torrent Pharmaceuticals Ltd. has experienced a significant rise in open interest within its derivatives segment, signalling heightened market participation and evolving positioning among traders. This development comes as the stock trades close to its 52-week high, reflecting a complex interplay of volume dynamics and investor sentiment in the Pharmaceuticals & Biotechnology sector."
      }
    ],
    "total": 922,
    "sid": "317368",
    "stock_news_url": "https://www.marketsmojo.com/news/torrent-pharmaceuticals-317368"
  },
  "announcements": [
    {
      "caption": "Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015",
      "datetime": "28-Nov-2025",
      "details": "Disclosure under regulation 30 of SEBI (Listing Obligation and Disclosure Requirements",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "28-Nov-2025",
      "details": "Newspaper advertisement in respect of special window for re-lodgement of transfer requests of physical shares",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "27-Nov-2025",
      "details": "Newspaper advt in respect of the transfer of shares to IEPF",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Torrent Pharmaceuticals Ltd. has declared <strong>520%</strong> dividend, ex-date: 31 Jan 25",
          "dt": "2025-01-31",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Torrent Pharmaceuticals Ltd. has announced <strong>5:10</strong> stock split, ex-date: 20 Feb 06",
          "dt": "2006-02-20",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Torrent Pharmaceuticals Ltd. has announced <strong>1:1</strong> bonus issue, ex-date: 08 Jul 22",
          "dt": "2022-07-08",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Torrent Pharmaceuticals: Analytical Perspective Shifts Amid Mixed Technical and Financial Signals

2025-12-02 08:32:49

Torrent Pharmaceuticals has experienced a revision in its market assessment following a detailed review of its technical indicators, valuation metrics, financial trends, and overall quality parameters. This nuanced shift reflects a complex interplay of factors influencing the pharmaceutical giant’s current standing in the market.

Read More

Is Torrent Pharma technically bullish or bearish?

2025-12-02 08:25:25

Technical Trend Overview

As of 1 December 2025, Torrent Pharma’s technical trend has moderated from bullish to mildly bullish. This subtle shift suggests that while the stock retains an overall positive momentum, some caution is warranted given mixed signals from various technical tools. Investors should consider this tempered optimism in the context of broader market conditions and sector dynamics.

Key Technical Indicators

The Moving Average Convergence Divergence (MACD) indicator offers a split view: weekly data remains bullish, signalling short-term momentum in favour of buyers, whereas the monthly MACD is mildly bearish, hinting at some longer-term caution. This divergence suggests that while recent price action is positive, underlying momen...

Read More

Technical Momentum Shift Observed in Torrent Pharmaceuticals Amid Mixed Indicator Signals

2025-12-02 08:03:49

Torrent Pharmaceuticals has experienced a nuanced shift in its technical momentum, reflecting a complex interplay of bullish and mildly bearish signals across key indicators. This development invites a closer examination of the stock’s price action and technical parameters amid the broader Pharmaceuticals & Biotechnology sector.

Read More

How has been the historical performance of Torrent Pharma?

2025-12-01 23:14:30

Revenue and Profit Growth

Over the seven-year period ending March 2025, Torrent Pharma’s net sales have shown a steady upward trend, increasing from ₹7,673 crores in 2019 to ₹11,516 crores in 2025. This represents a compound growth trajectory reflecting the company’s expanding market presence and product portfolio. The operating profit margin has also improved, rising from 26.6% in 2019 to 32.9% in 2025, signalling enhanced operational efficiency and cost management.

Profit after tax (PAT) has seen a significant rise, from ₹436 crores in 2019 to ₹1,911 crores in 2025. This growth is supported by a consistent increase in earnings per share (EPS), which climbed from ₹25.76 in 2019 to ₹56.46 in 2025, indicating strong shareholder value creation. The PAT margin improved fr...

Read More

Torrent Pharmaceuticals Sees Shift in Market Assessment Amid Strong Financial and Technical Signals

2025-11-27 08:09:12

Torrent Pharmaceuticals has experienced a notable revision in its market evaluation, reflecting a combination of robust financial performance, evolving technical indicators, and valuation considerations. This article analyses the key factors influencing the recent shift in the company’s assessment across quality, valuation, financial trends, and technical parameters.

Read More

Technical Momentum Shifts Signal New Phase for Torrent Pharmaceuticals

2025-11-27 08:01:58

Torrent Pharmaceuticals has exhibited a notable shift in its technical momentum, reflecting evolving market dynamics within the Pharmaceuticals & Biotechnology sector. Recent assessment changes highlight a transition towards a more bullish technical stance, supported by key indicators such as MACD, moving averages, and Bollinger Bands, while some oscillators present a more nuanced picture.

Read More

Surge in Open Interest Signals Shifting Market Dynamics for Torrent Pharmaceuticals

2025-11-24 15:00:19

Torrent Pharmaceuticals has witnessed a notable surge in open interest within its derivatives segment, reflecting evolving market positioning and potential directional bets. This development comes amid a backdrop of mixed volume patterns and price movements, offering investors a nuanced view of the stock’s near-term outlook.

Read More

Surge in Open Interest Signals Shifting Market Dynamics for Torrent Pharmaceuticals

2025-11-24 14:00:20

Torrent Pharmaceuticals has witnessed a notable surge in open interest within its derivatives segment, reflecting evolving market positioning and potential directional bets. This development comes amid a backdrop of mixed price action and changing volume patterns, offering investors a nuanced view of the stock’s near-term outlook.

Read More

Torrent Pharmaceuticals Sees Notable Surge in Open Interest Amidst Market Activity

2025-11-20 15:00:20

Torrent Pharmaceuticals Ltd. has experienced a significant rise in open interest within its derivatives segment, signalling heightened market participation and evolving positioning among traders. This development comes as the stock trades close to its 52-week high, reflecting a complex interplay of volume dynamics and investor sentiment in the Pharmaceuticals & Biotechnology sector.

Read More

View All News